Swisscanto (CH) Index Equity Fund World ex CH NTH1 CHF

Reference Data

ISIN CH1378606144
Valor Number 137860614
Bloomberg Global ID
Fund Name Swisscanto (CH) Index Equity Fund World ex CH NTH1 CHF
Fund Provider Swisscanto Fondsleitung AG Zurich
E-Mail: fonds@swisscanto.ch
Fund Provider Swisscanto Fondsleitung AG
Representative in Switzerland
Distributor(s) Schweizerische Kantonalbanken
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Switzerland
Issuing Condition The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets)
Redemption Condition The fund management company and/or distributor charges a redemption commission (different commissions can be charged for the same fund depending on the sales channel)
Investment Strategy *** The investment objective of the fund is to replicate the risk and return characteristics of the reference index.The fund primarily invests directly and indirectly in shares and other equity securities that are contained in the reference index.The use of derivatives equates to neither leveraging nor short selling with regard to the fund assets.
Peculiarities

Fund Prices

Current Price * 102.62 CHF 13.11.2024
Previous Price * 102.72 CHF 12.11.2024
52 Week High * 103.18 CHF 11.11.2024
52 Week Low * 98.81 CHF 31.10.2024
NAV * 102.62 CHF 13.11.2024
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 958,117,169
Unit/Share Assets *** 19,301,710
Trading Information SIX

Performance

YTD Performance - -
1 month +1.03% 14.10.2024
13.11.2024
3 months +2.62% 30.09.2024
13.11.2024
6 months - -
1 year - -
2 years - -
3 years - -
5 years - -

Tax Data

Equity Participation Rate in % 94.95
Share of Total Fund Assets in %
Real Estate Rate in % 0.00
ADDI
ADDI Date

Top 10 Holdings ***

Xtrackers MSCI USA ETF 1C 24.20%
iShares MSCI USA ETF USD Acc 24.06%
iShares Core S&P 500 ETF USD Acc 9.41%
Vanguard S&P 500 ETF USD Acc 9.41%
E-mini S&P 500 Future Sept 24 1.21%
Novo Nordisk A/S Class B 0.66%
ASML Holding NV 0.53%
AstraZeneca PLC 0.41%
Shell PLC 0.33%
SAP SE 0.33%
Last data update 31.08.2024

Cost / Risk

TER
TER date
Performance Fee ***
PTR
Max. Management Fee *** 0.00%
Ongoing Charges ***
SRRI ***
SRRI date *** 31.10.2024

ESG Fund Ratings

Low Carbon Designation ***
ESG Rating Overall ***
ESG Rating Corporate ***
ESG Rating Sovereign ***
% AuM H&S Controversies ***

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***

ESG Carbon Metrics

Avg Carbon Risk Score ***
Avg Carbon Risk Cat Avg ***
% AuM Covered Carbon ***
Avg Fossil Fuel Exposure ***
Fossil Fuel Cat Avg ***

ESG Strategy

Strategy Level 1 ***
Strategy Level 2 ***
Strategy Level 3 ***
Exclusions Level 1 ***
Exclusions Level 2 ***

* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)